Learn Before
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults
Clift, A. K., Coupland, C. A. C., Keogh, R. H., Hemingway, H., & Hippisley-Cox, J. (2021, April). Covid-19 mortality risk in Down Syndrome: Results from a cohort study of 8 million adults. Annals of internal medicine. Retrieved July 24, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592804/#:~:text=Sixty%2Deight%20persons%20with%20Down,65.3%25)%20of%20other%20causes.
0
1
Tags
Disability Studies
Social Science
Empirical Science
Science
Related
National Down Syndrome Society (NDSS): About Down Syndrome
Models of Down's syndrome in Mice
Down syndrome--genetic and nutritional aspects of accompanying disorders
Down syndrome: Description
Data and Statistics on Down Syndrome
Racial Disparity in Health Outcomes Among People with Down Syndrome
Down Syndrome Trends by Race/Ethnicity in the United States from 2012-2018.
Sociodemographic Differences in Prenatal Diagnosis of Chromosomal Anomalies: A Population-Based Study
Who is at risk for Down syndrome?
Racial/ethnic differences in hospital use and cost among a statewide population of children with down syndrome
Contributions to Racial Disparity in Mortality among Children with Down Syndrome
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults
Employment in adults with Down syndrome
Disparities and outcomes of patients living with Down Syndrome undergoing healthcare transitions from pediatric to adult care: A scoping review
Doctors accused of discriminating against Down's syndrome patients
What you need to know about insurance for children with Down Syndrome
Measurement of Family Management in Families of Individuals With Down Syndrome: A Cross-Cultural Investigation.
Protecting Individuals with Down Syndrome Act
Withholding Treatment from Defective Infants: Infant Doe Postmortem